Filing Flows

Filing Flows › Companies › Ingevity › Cash flow

Ingevity cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$85.5M in Q3 2026 · $123M over twelve months

Operating cash flow$99.2M
Capital spending−$13.7M
Free cash flow+$85.5M
Cash / net income2.0×

Analysis

In Q3 2026, Ingevity generated $99.2M of operating cash flow and spent $13.7M on capital projects, leaving free cash flow of $85.5M. That is $32.3M less than in Q3 2025 ($118M).

Over the twelve months to Sep 30, 2026, operating cash flow was $180M; the largest uses were other financing ($1.1B), buybacks ($156M), capital spending ($57.9M); besides operations, cash came from net borrowing (+) / repaid (−) ($1.0B), other investing ($213M); the cash balance rose by $58.0M.

Operating cash flow was $99.2M against net income of $49.3M — 2.0× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$20.9M, deferred taxes +$11.9M, accrued liabilities +$10.8M.

Free cash flow

Ingevity: free cash flow by quarterIngevity: free cash flow by quarter$39.6MQ4 2024$15.4MQ1 2025$66.8MQ2 2025$118MQ3 2025$73.5MQ4 2025−$12.3MQ1 2026−$24.1MQ2 2026$85.5MQ3 2026
Operating cash flow less capital spending.
Ingevity: operating cash flow against capital spendingIngevity: operating cash flow against capital spendingOperating cash flowCapital spending$64.5M$24.9MQ4 2024$25.4M$10.0MQ1 2025$79.0M$12.2MQ2 2025$130M$11.9MQ3 2025$97.1M$23.6MQ4 2025−$2.0M$10.3MQ1 2026−$13.8M$10.3MQ2 2026$99.2M$13.7MQ3 2026
Latest (Q3 2026): Operating cash flow $99.2M, Capital spending $13.7M.

Capital allocation, year by year

Ingevity: where the cash came from (up) and went (down), by fiscal yearIngevity: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsBuybacksFY2021: Operating cash flow $293MFY2021: Net borrowing −$26.0MFY2021: Shares issued $4.7MFY2021: Capital spending −$104MFY2021: Buybacks −$109M$298MFY2021FY2022: Operating cash flow $313MFY2022: Net borrowing $1.4BFY2022: Shares issued $4.1MFY2022: Capital spending −$142MFY2022: Acquisitions −$344MFY2022: Buybacks −$145M$1.7BFY2022FY2023: Operating cash flow $205MFY2023: Net borrowing −$7.3MFY2023: Shares issued $4.7MFY2023: Capital spending −$110MFY2023: Buybacks −$92.1M$210MFY2023FY2024: Operating cash flow $129MFY2024: Net borrowing −$67.1MFY2024: Capital spending −$77.6M$129MFY2024FY2025: Operating cash flow $331MFY2025: Net borrowing −$194MFY2025: Shares issued $1.4MFY2025: Asset sales $3.6MFY2025: Capital spending −$57.7MFY2025: Buybacks −$56.3M$336MFY2025
Over these 5 years operating cash flow totalled $1.3B; the largest uses were capital spending ($491M) and buybacks ($403M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$85.4M
Debt$1.1B
Net debt$1.1B
Due within a year$156M

Ingevity funds itself: free cash flow was $123M over the last twelve months, and $85.4M of cash and investments stands against $1.1B of debt ($156M due within a year, 0.5× covered by cash).

Where the cash came from and went

Ingevity: sources (+) and uses (−) of cash, Q3 2026Ingevity: sources (+) and uses (−) of cash, Q3 2026Operating cash flow$99.2MNet borrowing (+) / repaid (−)−$54.7MBuybacks−$38.5MCapital spending−$13.7MCash drawn (+) / kept (−)$8.5MExchange rates−$2.8MOther investing$2.5MTaxes on employees’ shares−$600KShares issued$400KOther financing−$300K
Ingevity: sources (+) and uses (−) of cash, TTM to Q3 2026Ingevity: sources (+) and uses (−) of cash, TTM to Q3 2026Other financing−$1.1BNet borrowing (+) / repaid (−)$1.0BOther investing$213MOperating cash flow$180MBuybacks−$156MCash drawn (+) / kept (−)−$58.0MCapital spending−$57.9MTaxes on employees’ shares−$7.2MShares issued$7.0MNot reconciled−$1.4M

From profit to cash

Ingevity: net income to operating cash flow, Q3 2026Ingevity: net income to operating cash flow, Q3 2026Net income$49.3MDepreciation & amortization$20.9MStock-based pay$4.0MDeferred taxes$11.9MOther non-cash$5.1MReceivables$2.2MInventory−$500KPayables−$5.3MAccrued liabilities$10.8MPrepaid and other assets−$800KIncome taxes payable−$1.6MOther operating capital−$5.0MOperating cash flow$99.2M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingBuybacksNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$99.2M−$13.7M−$38.5M−$54.7M$400K$8.5M$85.5M
Q2 2026−$13.8M−$10.3M−$34.5M−$3.9M$2.5M−$25.6M−$24.1M
Q1 2026−$2.0M−$10.3M−$52.3M−$4.2M$3.3M−$42.7M−$12.3M
Q4 2025$97.1M−$23.6M−$31.1M$81.8M$800K$1.8M$73.5M
Q3 2025$130M−$11.9M−$25.2M−$69.7M$600K−$7.3M$118M
Q2 2025$79.0M−$12.2M—−$62.8M—−$16.2M$66.8M
Q1 2025$25.4M−$10.0M—−$8.0M—−$4.3M$15.4M
Q4 2024$64.5M−$24.9M—$373M—$66.9M$39.6M

Ingevity: income statement and cash flow

Ingevity, Q3 2026: revenue $305M (-8% year over year), operating margin 22.0%. The chart follows the revenue to costs, profit and cash.

Ingevity: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.